Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment.

Pengo V, Barbero F, Biasiolo A, Pegoraro C, Cucchini U, Iliceto S.

Am J Clin Pathol. 2003 Dec;120(6):944-7.

PMID:
14671984
[PubMed - indexed for MEDLINE]
Free Article
2.

Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.

Pelicano N, Branco LM, Pinto A, Sá A, Timóteo AT, Feliciano J, Fiarresga A, Agapito AF, Palma MC, Quininha J.

Rev Port Cardiol. 2005 Jul-Aug;24(7-8):957-68. English, Portuguese.

PMID:
16240682
[PubMed - indexed for MEDLINE]
Free Article
3.

Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement.

Koertke H, Zittermann A, Minami K, Tenderich G, Wagner O, El-Arousy M, Krian A, Ennker J, Taborski U, Klövekorn WP, Moosdorf R, Saggau W, Morshuis M, Koerfer J, Seifert D, Koerfer R.

Ann Thorac Surg. 2005 Jun;79(6):1909-14; discussion 1914.

PMID:
15919283
[PubMed - indexed for MEDLINE]
4.

AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.

Acar J, Iung B, Boissel JP, Samama MM, Michel PL, Teppe JP, Pony JC, Breton HL, Thomas D, Isnard R, de Gevigney G, Viguier E, Sfihi A, Hanania G, Ghannem M, Mirode A, Nemoz C.

Circulation. 1996 Nov 1;94(9):2107-12.

PMID:
8901659
[PubMed - indexed for MEDLINE]
Free Article
5.

LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial.

Torella M, Torella D, Chiodini P, Franciulli M, Romano G, De Santo L, De Feo M, Amarelli C, Sasso FC, Salvatore T, Ellison GM, Indolfi C, Cotrufo M, Nappi G.

Am Heart J. 2010 Jul;160(1):171-8. doi: 10.1016/j.ahj.2010.05.005.

PMID:
20598989
[PubMed - indexed for MEDLINE]
6.

Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.

Ageno W, Turpie AG, Steidl L, Ambrosini F, Cattaneo R, Codari RL, Nardo B, Venco A.

Am J Cardiol. 2001 Jul 1;88(1):40-4.

PMID:
11423056
[PubMed - indexed for MEDLINE]
7.

Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients-.

Mori T, Asano M, Ohtake H, Bitoh A, Sekiguchi S, Matsuo Y, Aiba M, Yamada M, Kawada T, Takaba T.

Ann Thorac Cardiovasc Surg. 2002 Apr;8(2):83-7.

PMID:
12027793
[PubMed - indexed for MEDLINE]
Free Article
8.

International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.

Eitz T, Schenk S, Fritzsche D, Bairaktaris A, Wagner O, Koertke H, Koerfer R.

Ann Thorac Surg. 2008 Mar;85(3):949-54; discussion 955. doi: 10.1016/j.athoracsur.2007.08.071.

PMID:
18291177
[PubMed - indexed for MEDLINE]
9.

A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.

Pengo V, Barbero F, Banzato A, Garelli E, Noventa F, Biasiolo A, Zasso A, Dalla Volta S.

Thromb Haemost. 1997 May;77(5):839-44.

PMID:
9184389
[PubMed - indexed for MEDLINE]
10.

Mechanical heart valve patients can manage oral anticoagulant therapy themselves.

Christensen TD, Andersen NT, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM.

Eur J Cardiothorac Surg. 2003 Mar;23(3):292-8. Review.

PMID:
12614796
[PubMed - indexed for MEDLINE]
11.

Risks of oral anticoagulant therapy with increasing age.

Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.

Arch Intern Med. 2005 Jul 11;165(13):1527-32.

PMID:
16009869
[PubMed - indexed for MEDLINE]
12.

The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study.

Gadisseur AP, Christiansen SC, VAN DER Meer FJ, Rosendaal FR.

J Thromb Haemost. 2007 May;5(5):931-6. Epub 2007 Jan 9.

PMID:
17229054
[PubMed - indexed for MEDLINE]
13.

INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.

Koertke H, Minami K, Boethig D, Breymann T, Seifert D, Wagner O, Atmacha N, Krian A, Ennker J, Taborski U, Klövekorn WP, Moosdorf R, Saggau W, Koerfer R.

Circulation. 2003 Sep 9;108 Suppl 1:II75-8.

PMID:
12970212
[PubMed - indexed for MEDLINE]
Free Article
14.

Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: a controlled follow-up study in Spain.

Duran-Parrondo C, Vazquez-Lago JM, Campos-Lopez AM, Figueiras A.

Drug Saf. 2011 Jun 1;34(6):489-500. doi: 10.2165/11588520-000000000-00000.

PMID:
21585221
[PubMed - indexed for MEDLINE]
15.

The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.

Parra D, Beckey NP, Stevens GR.

Pharmacotherapy. 2007 May;27(5):675-83.

PMID:
17461702
[PubMed - indexed for MEDLINE]
16.

[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].

Míka P, Behounek J, Skoták M, Nevsímal L.

Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44. Czech.

PMID:
15456102
[PubMed - indexed for MEDLINE]
17.

Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.

Torn M, Cannegieter SC, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.

Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176.

PMID:
19597069
[PubMed - indexed for MEDLINE]
18.

International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?

Körtke H, Körfer R.

Ann Thorac Surg. 2001 Jul;72(1):44-8.

PMID:
11465228
[PubMed - indexed for MEDLINE]
19.

[Increased acceptance of the International Normalized Ratio (INR) as a monitoring parameter of oral anticoagulation therapy in Germany. GELIA Study Group].

Horstkotte D, Bergemann R, Oelert H, Schulte HD, Laas J, Zerkowski HR.

Z Kardiol. 1998 Oct;87(10):837-43. German.

PMID:
9857460
[PubMed - indexed for MEDLINE]
20.

Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.

Koertke H, Zittermann A, Tenderich G, Wagner O, El-Arousy M, Krian A, Ennker J, Taborski U, Klövekorn WP, Moosdorf R, Saggau W, Koerfer R.

Eur Heart J. 2007 Oct;28(20):2479-84. Epub 2007 Sep 21.

PMID:
17890730
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk